Сообщения

Сообщения за Март, 2017

Edge: Die Meldung „Möchten Sie alle Tabs schließen?“ wieder reaktivieren

Изображение
Edge: Die Meldung „Möchten Sie alle Tabs schließen?“ wieder reaktivieren
Vom Firefox kennen wir die Warnmeldung, die bei der Browserbeendigung erscheint, dass noch mehrere Tabs geöffnet sind. Auch der Microsoft Edge zeigt diese Dialogbox. Soll die Warnung nicht mehr erscheinen, dann kann dies mit der Option Immer alle Tabs schließen erreicht werden. Der Nachteil: Beim Edge kann die Deaktivierung der Warnmeldung ohne größeren Aufwand nicht mehr rückgängig gemacht werden. Doch ein kleiner Registry-Tweak holt diese Nachricht bei Bedarf wieder schnell zurück.Edge-Neuinstallation nicht vorgesehenWährend man bei anderen Browsern recht einfach zu den Standardeinstellungen zurückkehren, oder eine Neuinstallation durchführen kann, ist das beim Edge nicht möglich. Eine De- oder Neuinstallation lässt Windows nicht zu. Edge kann zwar über PowerShell repariert werden, verliert dabei aber alle gespeicherten Favoriten, sowie die persönlichen Einstellungen.Registry ergänzenDurch das Hinzufügen des Reg…

Forward Pharma Falls On Biogen Patent Victory Over MS Drug Ingredient

Forward Pharma Falls On Biogen Patent Victory Over MS Drug Ingredient
Forward Pharma A/S plummeted 30 percent Friday on news of Biogen Inc 's patent victory over the active ingredient in their competing multiple sclerosis treatments. Biogen popped 1.5 percent on the news.

from Biotech News

FibroGen Announces China FDA Approval of CTA to Conduct Pivotal Phase ...

FibroGen Announces China FDA Approval of CTA to Conduct Pivotal Phase ...
FibroGen, Inc. , a science-based biopharmaceutical company, today announced the approval by the China Food and Drug Administration of the Company's clinical trial application in China for a Phase 2/3 pivotal trial of roxadustat in anemia associated with lower risk myelodysplastic syndromes . FibroGen and AstraZeneca are collaborating on the development and commercialization of roxadustat in China, the U.S., and other major markets.

from Biotech News

Evotec's Partner Forge Therapeutics Receives Prestigious CARB-X Research Award

Evotec's Partner Forge Therapeutics Receives Prestigious CARB-X Research Award
Forge will receive an initial award of $ 4.8 m over 15 months and potentially up to $ 4.0 m from CARB-X after that period upon achievement of certain milestones. CARB-X, launched in August 2016, is one of the world's largest public-private partnerships focused on pre-clinical discovery and development of new antimicrobial products.

from Biotech News

FDA Approves 1st Drug For Aggressive Multiple Sclerosis

FDA Approves 1st Drug For Aggressive Multiple Sclerosis
U.S. regulators have approved the first drug for an aggressive kind of multiple sclerosis that steadily reduces coordination and the ability to walk. The Food and Drug Administration approved Ocrevus late Tuesday after a large study found it slowed progression of the neurological disease and reduced symptoms.

from Biotech News

Astrazeneca Scores Milestone Victory In Oncology

Astrazeneca Scores Milestone Victory In Oncology
AstraZeneca stock was treading water on Friday despite the pharma titan receiving full approval from the U.S. Food and Drug Administration for a key drug within its oncology portfolio and announcing a licensing deal over another cancer treatment. The FDA granted Tagrisso 80mg once-daily tablets full approval for treatment of a T790M mutation-positive non-small cell lung cancer , after it was found superior than the one other available treatment - chemotherapy - for the condition.

from Biotech News

Swiss stocks - Factors to watch on March 31

Swiss stocks - Factors to watch on March 31
Johnson & Johnson declared its $30 billion tender offer for Swiss biotechnology company Actelion successful on Friday, reporting it controlled 77.2 percent of the voting rights after the main offer period. The price of the offer, which J&J announced on Jan. 26, was $280 per share for Actelion.

from Biotech News

Thunder and Lightning Cancels UC San Diego vs Valdosta State

Thunder and Lightning Cancels UC San Diego vs Valdosta State
PENSACOLA, Fla. Thursday's men's and women's tennis matches against Valdosta State have been cancelled due to unfavorable weather.

from Biotech News

SpyBiotech, which makes a 'superglue' for vaccines, raises A 4M from GV and Oxford

SpyBiotech, which makes a 'superglue' for vaccines, raises A 4M from GV and Oxford
You are about to activate our Facebook Messenger news bot. Once subscribed, the bot will send you a digest of trending stories once a day.

from Biotech News

Phase II Study of Daratumumab in Non-Hodgkin's Lymphoma Will Not Proceed to Stage 2 of Trial

Phase II Study of Daratumumab in Non-Hodgkin's Lymphoma Will Not Proceed to Stage 2 of Trial
Genmab A/S announced today that its collaboration partner for daratumumab, Janssen Biotech, Inc., has decided not to initiate stage 2 of the Phase II study of daratumumab in three types of relapsed or refractory non-Hodgkin's lymphoma . The study will not proceed to stage 2 as a data review showed that two cohorts of the study, investigating the use of daratumumab monotherapy in relapsed or refractory patients with follicular lymphoma , and with diffuse large B-cell lymphoma did not reach the predefined futility thresholds of overall response rates of 50%, and 30%, respectively.

from Biotech News

Weltweit ersten schützenden Antikörper gegen das Marburg-Virus entwickelt

Weltweit ersten schützenden Antikörper gegen das Marburg-Virus entwickelt
Ein Forschungs-Team um Professor Michael Hust vom Institut für Biochemie, Biotechnologie und Bioinformatik der Technischen Universität Braunschweig hat den weltweit ersten Antikörper entwickelt, der im Tiermodell gegen eine Infektion mit dem Marburg-Virus schützt. Das Team aus Wissenschaftlerinnen u...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

iDD biotech Enters Worldwide Exclusive Licence Concerning Antibodies and Patents Related to CK8

iDD biotech Enters Worldwide Exclusive Licence Concerning Antibodies and Patents Related to CK8
CK8 is expressed at the cell surface in cancer cells , in particular in colon cancer but also in head and neck carcinoma, in glioma as well as in lung cancers. iDD biotech, together with Lyon Cancer Research Center , hosted by the Centre Leon Berard , has developed humanized MAb targeting eCK8 and has gained spectacular in-vivo POC with tumour shrinkage and massive necrosis.

from Biotech News

Bristol-Myers Squibb Co (BMY) Director Lamberto Andreotti Sells 17,000 Shares

Bristol-Myers Squibb Co (BMY) Director Lamberto Andreotti Sells 17,000 Shares
Bristol-Myers Squibb Co Director Lamberto Andreotti sold 17,000 shares of the firm's stock in a transaction that occurred on Monday, March 27th. The stock was sold at an average price of $56.14, for a total transaction of $954,380.00.

from Biotech News

Finanzen: Forward-Darlehen : Forward-Darlehen

Aktuell sind die Bauzinsen auf niedrigem Niveau. Wir erklären Ihnen wie Sie sich mit Forward-Darlehen die Zinsen sichern.

from Finanztip Feed
Supported by Video Collection

Finanzen: bereitstellungszinsen : Zinsen auf ungenutzten Kredit

Bereitstellungszinsen machen insbesondere lange Bauvorhaben teuer. Achten Sie deshalb beim Abschluss von Baukrediten auf die bereitstellungszinsfreie Zeit.

from Finanztip Feed
Supported by Video Collection

Finanzen: Ratgeber Anschlussfinanzierung : Anschlussfinanzierung bei der Baufinanzierung

Wenn die Zinsbindung ausläuft, werden die Konditionen neu verhandelt. Werden Sie aktiv und vergleichen Sie Anbieter.

from Finanztip Feed
Supported by Video Collection

PeaceHealth announces more layoffs at labs in Oregon

PeaceHealth announces more layoffs at labs in Oregon
PeaceHealth is eliminating the jobs because of its decision to sell laboratories to Quest Diagnostics, a for-profit company based in New Jersey. The Register-Guard reports PeaceHealth announced the additional layoffs in a statement Wednesday.

from Biotech News

Finanzen: Ratgeber Photovoltaik : Solarstrom

Solarstrom zu produzieren lohnt sich, wenn Sie viel davon selbst verbrauchen. Dann versorgen Sie sich zu deutlich geringeren Kosten mit Strom, als die Energieversorger es anbieten.

from Finanztip Feed
Supported by Video Collection

Top Biotech Stocks for Growth Investors

Top Biotech Stocks for Growth Investors
We asked three of our healthcare specialists to name their favorite biotech growth stocks. Here's why they picked Omeros Corporation Cory Renauer : Sales of this biotech's pupil-dilating solution are growing so fast, I could hardly believe my eyes when I saw its latest earnings report.

from Biotech News

Roche: FDA-Komitee empfiehlt Rituximab bei bestimmten Blutkrebsarten

Roche: FDA-Komitee empfiehlt Rituximab bei bestimmten Blutkrebsarten
(dpa-AFX) Die Roche-Tochter Genentech vermeldet positive Neuigkeiten zu Rituximab. Ein beratendes Komitee der US-Gesundheitsbehörde FDA habe einstimmig die Zulassung des Medikaments zur subkutanen Verabreichung bei bestimmten Blutkrebsarten empfohlen, heisst es in einer Mitteilung vom Mittwochabend....

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Daimler shareholder demands right to be naked at annual meeting

Daimler shareholder demands right to be naked at annual meeting
Daimler AG's annual meeting threatened to veer off course for a second year after a shareholder pontificated on his right to be naked. Wilm Diedrich Mueller, well-known for pranking gatherings at companies ranging from Allianz SE to Bayer AG, used his allotted speaking time to criticize the board because he hadn't been invited to appear in "species-appropriate attire."

from Biotech News

Windows 10: Den alten Windows-7-Taskmanager zurückholen

Windows 10: Den alten Windows-7-Taskmanager zurückholen
Bereits mit Windows 8 wurde auch ein neuer Taskmanager eingeführt. Das Erscheinungsbild ist natürlich moderner und zusätzliche Funktionen wie die Registerkarte Autostart sind ebenfalls enthalten. Viele Nutzer klagen darüber, dass die neue Ansicht zu unübersichtlich ist. Darüber hinaus belegt der neue Taskmanager gegenüber der alten Version zuviel Arbeitsspeicher und Prozessorleistung. Bevorzugst du die Windows-7-Taskmanager-Version, dann kannst du dir diese wieder zurückholen.Auf der Webseite von Winaero gibt es den klassischen Taskmanager als kostenlosen Download. Zum Herunterladen ZIP-Datei klickst du einfach auf den Link Old Taskmanager for Windows 10.Nach dem Download entpackst du die ZIP-Datei an einem beliebigen Ort und startest die Installation des klassischen Taskmanagers mit einem Doppelklick auf die setup.exe. Dazu folgst du anschließend nur dem Installationsassistenten.Empfohlen: MSCONFIG direkt mitinstallierenBei der I…

Biotech Premarket Movers: Vertex, Sangamo, Depomed

Biotech Premarket Movers: Vertex, Sangamo, Depomed
Shares of Boston-based Vertex Pharmaceuticals jumped 21%, to $108.50, in premarket trading on Wednesday after the company on Tuesday night announced successful outcomes from two clinical trials involving tezacaftor, a second-generation "corrector" used in combination therapies to treat the underlying cause of cystic fibrosis. Meanwhile, shares of Sangamo Therapeutics were up 12.4%, to $4.55.

from Biotech News

Hedge Fund Sees 20 Percent Returns on Picks From Nobel Prize Winners

Hedge Fund Sees 20 Percent Returns on Picks From Nobel Prize Winners
Thanks to the advice from a range of professors, Swedish hedge fund Rhenman Healthcare Equity L/S has delivered an average annual return of 21 percent since it started in 2009. Asking clinical expertise before investing in complex products is a must for Henrik Rhenman, who manages the 460 million-euro fund.

from Biotech News

Leerink Swann Reiterates $448.00 Price Target for Regeneron Pharmaceuticals Inc

Leerink Swann Reiterates $448.00 Price Target for Regeneron Pharmaceuticals Inc
The firm presently has a "buy" rating on the biopharmaceutical company's stock. Leerink Swann's price objective indicates a potential upside of 17.11% from the company's current price.

from Biotech News

Finanzen: Berufsunfähigkeitsversicherung : Berufsunfähigkeitsversicherung

Wie finanzieren Sie Ihr Leben, wenn Sie plötzlich nicht mehr arbeiten können? So finden Sie die richtige Versicherung gegen Berufsunfähigkeit.

from Finanztip Feed
Supported by Video Collection

Finanzen: Gesetzliche Rentenversicherung : Gesetzliche Rentenversicherung

Die gesetzliche Rente ist für die meisten im Alter unverzichtbar. Wir erklären, wie sie funktioniert, wie hoch sie ausfällt und warum das Rentenniveau sinken wird.

from Finanztip Feed
Supported by Video Collection

Vertex cystic fibrosis combination succeeds in late stage trials

Vertex cystic fibrosis combination succeeds in late stage trials
Vertex Pharmaceuticals Inc on Tuesday said its Kalydeco cystic fibrosis treatment given with an experimental drug demonstrated significant improvements in lung function in a pair of late stage trials the company plans to use to seek approval of the combination therapy. Patient discontinuations of the Kalydeco/tezacaftor combination due to adverse side effects, including respiratory-related side effects, was low and similar to placebo.

from Biotech News

Finanzen: Wertpapierdepot : Test Online-Wertpapierdepot

Wer in Wertpapiere investieren will, braucht ein Depot. Wir haben untersucht, wo Sie besonders preiswert online Aktien handeln können und welche Depotbanken am benutzerfreundlichsten sind.

from Finanztip Feed
Supported by Video Collection

Evotec profitiert von Kooperationen

Evotec profitiert von Kooperationen
(dpa-AFX) Das Hamburger Biotech-Unternehmen Evotec blickt nach einem Umsatzsprung optimistisch auf das laufende Jahr. Der Umsatz soll um mehr als 15 Prozent wachsen, teilte das Unternehmen am Dienstag in Hamburg mit. Im vergangenen Jahr profitierte die Gesellschaft von Kooperationen mit großen Pharm...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

The FDA just approved a new drug to treat eczema that costs $37,000 a year

The FDA just approved a new drug to treat eczema that costs $37,000 a year
The FDA on Tuesday approved Regeneron Pharmaceuticals and Sanofi's Dupixent for treatment of moderate to severe atopic dermatitis, a product widely seen as the most important future growth driver for the two companies. Atopic dermatitis is a chronic type of skin inflammation also known as eczema, which in severe cases causes intense constant itching.

from Biotech News

Roche erhält FDA-Zulassung für Ocrevus zur Behandlung von MS

Roche erhält FDA-Zulassung für Ocrevus zur Behandlung von MS
(dpa-AFX) Roche hat einen wichtigen Punktsieg erzielt. Die US-Gesundheitsbehörde FDA hat dem Mittel Ocrevus zur Behandlung von Multipler Sklerose (MS) die Zulassung erteilt, wie die Roche-Tochter Genentech in der Nacht auf Mittwoch mitteilte. Nachdem die Prüfungsfrist Ende Dezember noch verlängert w...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Umworbener Stada-Konzern muss Gewinnschwund verkraften

Umworbener Stada-Konzern muss Gewinnschwund verkraften
(dpa-AFX) Mitten im Bieterwettrennen um Stada muss der Pharmakonzern einen deutlichen Gewinnrückgang für das vergangene Jahr verkraften. Der Geschäftsumbau des von zwei Finanzkonsortien umworbenen MDax-Konzerns hinterließ 2016 sichtbare Spuren in der Bilanz. Durch die Neubewertung einer kniffligen T...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Finanzen: Mietminderung : Ratgeber Mietminderung

Der Alptraum eines jeden Mieters: ein Wasserrohrbruch, Schimmel, Baulärm oder eine kaputte Heizung. Das sind alles Gründe, um die Miete zu mindern. Doch dabei gibt es einiges zu beachten.

from Finanztip Feed
Supported by Video Collection

3 Least Risky Biotech Stocks on the Market

3 Least Risky Biotech Stocks on the Market
There's nothing like reliable earnings growth to keep a stock from sinking. Celgene can claim perhaps the most rock-solid growth prospects of any biotech.

from Biotech News

Funktioniert doch: Die Google Bildersuche für´s Handy

Funktioniert doch: Die Google Bildersuche für´s Handy
Das man mit der Google-Suchmaschine auch eine Bildersuche durchführen kann, ist hinlänglich bekannt. Foto hochladen, Suche starten, auf das Ergebnis warten, fertig. Leider ist die Google Bildersuche aber nur mit dem PC oder einem Notebook möglich, bei mobilen Geräten wie Smartphones und Tablets wird diese Funktion nicht angeboten. Doch mit dem (kostenlosen) Onlinedienst CTRLQ des Entwicklers Amit Agarwal wird die Google Bildersuche wieder möglich.Um eine Bildersuche mit deinem Handy oder dem Tablet durchzuführen, rufst du in deinem mobilen Browser die Webseite http://ift.tt/1TAlkp4 auf. Tippe dann auf den Button Upload Picture und navigiere über den nachfolgenden Dialog zum Speicherplatz (z. B. Galerie) des Handys.Wähle nun das Bild aus, dass du für die Suche hochladen möchtest. Der Upload startet dann automatisch. Nach ein paar Sekunden lässt du dir die Ergebnisse durch Tippen auf die Schaltfläche Show Matches anzeigen.

Supported b…

Johnson & Johnson Advocate Says It Should Not Be Defendant in Baby Powder Case

Johnson & Johnson Advocate Says It Should Not Be Defendant in Baby Powder Case
The Personal Care Products Council wants its name off the defendants' list in multidistrict litigation filed in U.S. District Court in New Jersey by plaintiffs suing Johnson & Johnson over the pharmaceutical giant's baby powder. The nonprofit operates as a national cosmetics-industry trade association that has more than 600 members Johnson & Johnson is one of them paying annual dues.

from Biotech News

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings
Manitou is a leader ... )--Revcontent announces its growth to the largest content recommendation network. According to Quantcast, Revcontent reaches 97% of US households, putting their reach ... )--Silver Spring Networks, Inc. today disclosed that, in connection with the appointment of Ms.

from Biotech News

Neuer Einspruch gegen Patent auf teuren Hepatitis-C-Wirkstoff

Neuer Einspruch gegen Patent auf teuren Hepatitis-C-Wirkstoff
(dpa) Nicht-Regierungsorganisationen kämpfen weiter gegen Patente auf ein sehr wirksames, aber teures Medikament gegen die Leberentzündung Hepatitis C. Die Organisation Ärzte der Welt, Ärzte ohne Grenzen und knapp 30 andere Organisationen reichten am Montag beim Europäischen Patentamt (EPA) einen Ei...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Soziale Medien ändern Wahrnehmung von Forschung

Изображение
Soziale Medien ändern Wahrnehmung von Forschung

(dpa) Soziale Medien verändern die Wahrnehmung von Wissenschaft in der Bevölkerung. Dabei gebe es negative Entwicklungen ebenso wie positive, sagte der Präsident der Max-Planck-Gesellschaft (MPG), Martin Stratmann, im Interview mit der Deutschen Presse-Agentur. Eine Ursache für Glaubwürdigkeitsprobl...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Finanzen: Kündigungsfristen im Mietrecht : Kündigungsfristen im Mietrecht

Sie müssen umziehen und die Wohnung kündigen: Diese Fristen müssen Sie als Mieter und Vermieter beachten.

from Finanztip Feed
Supported by Video Collection

Windows 10: Die Taskleisten-Uhr mit Sekundenanzeige ausstatten

Windows 10: Die Taskleisten-Uhr mit Sekundenanzeige ausstatten
In allen Windows-Betriebssystemen wird die Uhrzeit in der Taskleiste nur in Stunden und Minuten angezeigt. Da macht auch Windows 10 keine Ausnahme. In der Betaphase von Windows 10 (damals noch Windows 9.x) wurde bereits mit der kompletten Uhrzeit experimentiert. Gerüchten zufolge wurde die Sekundenanzeige aber wieder deaktiviert, da sie zu Performance-Problemen geführt haben soll. Die Problematik wurde inzwischen beseitigt, aber die Sekundenanzeige blieb bisher ausgeblendet. Mit einer kleine Registry-Änderung kannst du deine Systemzeit um die Sekunden erweitern.Starte dazu deinen Registrierungseditor über das Fenster Ausführen und dem Befehl regedit. Anschließend navigierst du zu folgendem Registryschlüssel:H_KEY_CURRENT_USER\SOFTWARE\Microsoft\Windows\CurrentVersion\Explorer\AdvancedIm rechen Anzeigebereich führst du einen Rechtsklick aus und wählst im Kontextmenü Neu | DWORD-Wert (32-Bit). Den neuen Schlüssel nennst du Sh…

Finanzen: Eigenbedarfskündigung : Ratgeber Eigenbedarfskündigung

Eigenbedarf ist der häufigste Kündigungsgrund. Aber nicht jede Kündigung ist zulässig. Ob Sie Ihre Wohnung räumen müssen oder wie Sie sich erfolgreich wehren können, lesen Sie hier.

from Finanztip Feed
Supported by Video Collection

Finanzen: Mahngebühren : Mahngebühren und Inkassokosten

Wer seine Rechnung zu spät überwiesen hat, soll meist noch zusätzlich Mahngebühren zahlen. Oft sind Mahnkosten allerdings zu hoch und damit unzulässig.

from Finanztip Feed
Supported by Video Collection

Finanzen: Kündigungsfristen im Arbeitsrecht : Kündigungsfristen

Wenn Sie Ihren Job wechseln wollen, müssen Sie Ihre Kündigungsfrist beachten. Wonach sich diese richtet, lesen Sie in unserem Ratgeber.

from Finanztip Feed
Supported by Video Collection

Finanzen: Probezeit im Arbeitsrecht : Probezeit im Arbeitsrecht

Jeder neue Job beginnt mit einer Probezeit. Der Arbeitgeber darf dem Einsteiger in dieser Phase ohne Angabe von Gründen kündigen. An bestimmte Kündigungsfristen müssen sich beide Seiten aber trotzdem halten.

from Finanztip Feed
Supported by Video Collection

Finanzen: Kfz-Versicherung : Kfz-Versicherung

Wenn Sie bei der Kfz-Versicherung sparen möchten, kommen Sie um einen Onlinevergleich nicht herum. Wir zeigen Ihnen, wie Sie verschiedene Vergleichsportale clever kombinieren, um den günstigsten und besten Tarif zu bekommen.

from Finanztip Feed
Supported by Video Collection

Sanofi and Regeneron Take Aim on Amgen IL-4 Receptor Patent

Sanofi and Regeneron Take Aim on Amgen IL-4 Receptor Patent
This week Sanofi-Aventis and Regeneron Pharmaceuticals took aim at Amgen's U.S. Patent No. 8,679,487 on two fronts, filing a declaratory judgment action in district court and a petition for inter partes review in the U.S. Patent & Trademark Office.

from Biotech News

13 Actionable Strategies From 13 Entrepreneurial Podcasts

13 Actionable Strategies From 13 Entrepreneurial Podcasts
By now, you've probably listened to a podcast episode or two in your life. There are a host of great podcasts that can give you strategies, inspiration and tools to help your business grow.

from Biotech News

As Americans fail drug tests, employers turn to refugees

As Americans fail drug tests, employers turn to refugees
Inside a factory near this lakeside city, a man holding a blowtorch is putting the finishing touches on a plastic rain barrel that will soon make its way to a home and garden section somewhere in America. He is Talib Alzamel, a 45-year-old Syrian refugee who arrived here last summer with his wife and five children.

from Biotech News

Infant mortality improves in South Carolina

Infant mortality improves in South Carolina
A report from the Centers for Disease Control and Prevention shows that South Carolina has made progress in reducing the infant death rate in the state. The Post and Courier of Charleston reported that the infant mortality rate in South Carolina dropped nearly 21 percent between 2005 and 2014.

from Biotech News

3 Near-Term Runners To Buy On The Current Weakness In Biotech

3 Near-Term Runners To Buy On The Current Weakness In Biotech
Management at Adamis Pharmaceuticals believes the third time is the charm for gaining approval for their cheaper alternative to the Epi-Pen. Recent recall at Mylan aids the case.

from Biotech News

Gilead hepatitis C drug patent faces European challenge

Gilead hepatitis C drug patent faces European challenge
Two international medical humanitarian organisations said on Monday they had challenged the patent on Gilead Sciences' hepatitis C drug sofosbuvir at the European Patent Office in order to increase access to the treatment. Sofosbuvir, sold by the U.S. drugmaker as Sovaldi, is transforming the liver-destroying viral disease by offering an effective cure, but Medecins Sans Frontieres and Medecins du Monde said its high cost was a serious barrier.

from Biotech News

Alexion Appoints Ludwig Hantson, Ph.D., as Chief Executive Officer

Alexion Appoints Ludwig Hantson, Ph.D., as Chief Executive Officer
Alexion Pharmaceuticals, Inc. today announced that its Board of Directors has appointed Ludwig N. Hantson, Ph.D., as Chief Executive Officer and member of the Board of Directors, effective immediately. Dr. Hantson most recently served as President and CEO of Baxalta, a successful spin-off as a public company from Baxter, and a global leader in the development of therapies for orphan and underserved diseases in hematology, immunology and oncology.

from Biotech News

Scientists call for better basic-clinical genomic research collaborations

Scientists call for better basic-clinical genomic research collaborations
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory , National Human Genome Research Institute and institutions across the U.S. declare in a Leading Edge commentary in Cell . "Interactions between basic and clinical researchers should be more like a 'virtuous cycle' of bench to bedside and back again," says JAX Professor Carol Bult, Ph.D., senior author of the commentary.

from Biotech News

Finanzen: Kreditkarte ohne Schufa : Kreditkarte ohne Schufa-Abfrage

Die Bewertung durch die Schufa ist negativ? Betroffene können trotzdem eine Kreditkarte bekommen. Denn Anbieter von Prepaid-Kreditkarten kommen oft ohne Schufa-Prüfung aus.

from Finanztip Feed
Supported by Video Collection

Finanzen: Auslandsreisekrankenversicherung : Auslandsreise-Krankenversicherung

Sie darf weder beim Familienurlaub noch bei der Geschäftsreise außerhalb Deutschlands fehlen: die Auslandsreisekrankenversicherung.

from Finanztip Feed
Supported by Video Collection

Cytori Therapeutics Inc (CYTX) Given a $10.00 Price Target by Maxim Group Analysts

Cytori Therapeutics Inc (CYTX) Given a $10.00 Price Target by Maxim Group Analysts
The firm presently has a "buy" rating on the stock. A number of other equities research analysts have also weighed in on the stock.

from Biotech News

Eli Lilly and Co (LLY) Downgraded by Vetr Inc. to "Strong Sell"

Eli Lilly and Co (LLY) Downgraded by Vetr Inc. to "Strong Sell"
They currently have a $70.44 price target on the stock. Vetr 's price objective points to a potential downside of 16.32% from the stock's current price.

from Biotech News

Pokern, buhlen, hinhalten: Der zähe Übernahmekampf um Stada

Pokern, buhlen, hinhalten: Der zähe Übernahmekampf um Stada
(dpa) Advent und Permira, Bain und Cinven: Zwei Bietergruppen ringen um Stada. Sie wollen je 3,6 Milliarden Euro für den MDax-Konzern zahlen. Doch das reicht Stada nicht. Während das Management den Preis für eine mögliche Übernahme hoch treiben will, gibt es immer wieder Turbulenzen. Wie geht es wei...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Biotest blitzt bei Kooperationspartner ab

Biotest blitzt bei Kooperationspartner ab
(dpa-AFX) Schlechte Nachrichten für das Biotechunternehmen Biotest: Der Kooperationspartner ImmunoGen aus den USA will sich nicht an der Entwicklung und Vermarktung eines Antikörper-Wirkstoff-Konjugats von Biotest in den USA beteiligen. Das teilte das im SDax notierte Unternehmen am Freitag mit. Dad...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Shire PLC (SHP) Price Target Raised to GBX 4,550

Shire PLC (SHP) Price Target Raised to GBX 4,550
The firm presently has a "hold" rating on the biopharmaceutical company's stock. HSBC Holdings plc's price objective points to a potential downside of 2.71% from the stock's previous close.

from Biotech News

Spring arts: At 15, Zion Dyson jazzed in a big way about singing and 'digging the cats'

Spring arts: At 15, Zion Dyson jazzed in a big way about singing and 'digging the cats'
Zion Dyson earned a standing ovation at Tuesday's San Diego Music Awards for her bravura performance of the Ella Fitzgerald classic, "Air Mail Special." Zion Dyson earned a standing ovation at Tuesday's San Diego Music Awards for her bravura performance of the Ella Fitzgerald classic, "Air Mail Special."

from Biotech News

3 Top Biotech Stocks to Buy in 2017

3 Top Biotech Stocks to Buy in 2017
Here's a closer look at why all three companies could be great investment candidates. Acadia Pharmaceuticals has been a home run stock over the last few years thanks to investor enthusiasm around its drug Nuplazid.

from Biotech News

Illumina, Inc. (ILMN) Upgraded to Strong-Buy by Vetr Inc.

Illumina, Inc. (ILMN) Upgraded to Strong-Buy by Vetr Inc.
The brokerage currently has a $187.82 price objective on the life sciences company's stock. Vetr 's price objective would suggest a potential upside of 10.11% from the stock's current price.

from Biotech News

AstraZeneca plc (AZN) Given "Buy" Rating at Deutsche Bank AG

AstraZeneca plc (AZN) Given "Buy" Rating at Deutsche Bank AG
's stock had its "buy" rating reiterated by equities research analysts at Deutsche Bank AG in a research note issued on Tuesday. They presently have a GBX 5,500 price objective on the biopharmaceutical company's stock.

from Biotech News

Marketplace Roundtable: Biotech Hanging In The Balance

Marketplace Roundtable: Biotech Hanging In The Balance
As Capitol Hill swirls around the possibility of a new healthcare bill, biotech investors would do well to keep an eye on developments. But there are other areas of the industry to focus on, whether M&A activity, oncology progress, CRISPR innovations, or plain old mean reversion.

from Biotech News

A New Marijuana Medicine Gets DEA Scheduling, but It's Not All Good News

A New Marijuana Medicine Gets DEA Scheduling, but It's Not All Good News
This week, the DEA finally announced that it's labelingSyndros as a Schedule II drug, and while that scheduling clears the way for Insys Therapeutics to begin marketing it, the DEA's decision fell short of the Schedule III rating that investors really wanted. Syndros is a liquid formulation of the THC drug Marinol, a medicine that's been used to treat anorexia in AIDS patients and chemotherapy-induced nausea and vomiting since the 1980s.

from Biotech News

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings
T... )--Scout Investments, Inc. announced today that the Scout Mid Cap Fund received a 2017 Lipper Fund Award as best mid-cap core fund for the 10-year pe... PrismTech to Demonstrate Open Source FACE 2.1 Transport Services Segment Reference Implementation at Air Force FACE Technical Interchange Meeting )--PrismTech to Demonstrate Open Source FACE 2.1 Transport Services Segment Reference Implementation at Air Force Future Airborne Capability Environment Technical... )--Today, Citizens Against Government Waste named Sen. Al Franken its March 2017 Porker of the Month for his absurd defense of the bureaucratic takeover o... )--Zachry Holdings, Inc. announces its year-end bondholder conference call will be held on Friday, April 7, 2017, at 10:00 a.m. .

from Biotech News

Quantity - Not Quality - Counts for Patent Infringement: More Than...

Quantity - Not Quality - Counts for Patent Infringement: More Than...
The U.S. Supreme Court recently held in a recent decision in Life Technologies Corp v. Promega Corp. that the "supply of a single component of a multicomponent invention for manufacture abroad does not give rise to 271 liability."

from Biotech News

Five killed, at least 40 injured in London terror attack

Five killed, at least 40 injured in London terror attack
Detectives are continuing to search two homes in Birmingham and another in East London linked to the attacker, after completing others elsewhere in London , Birmingham, Manchester, Brighton, Surrey and Camarthenshire in Wales. Police also said they seized more than 2,700 items, which includes " massive amounts of computer data ".

from Biotech News

3 Hot Biotech Stocks Now

3 Hot Biotech Stocks Now
Cara Therapeutics, Aurinia Pharmaceuticals, and Esperion Therapeutics are clinical-stage drug developers with their eyes set on multibillion dollar markets. Biotechnology stocks have been on a roller coaster ride.

from Biotech News

Leather maker, Lyme tester among tech grants in Maine

Leather maker, Lyme tester among tech grants in Maine
A company that makes leather products and a startup that wants to design a new Lyme disease test are among the recipients of more than $1 million in grants from the Maine Technology Institute. The institute says it has approved 25 awards that will support innovation all around the state.

from Biotech News

The Teva Pharmaceutical Industries Ltd (TEVA) Lowered to Buy at Vetr Inc

The Teva Pharmaceutical Industries Ltd (TEVA) Lowered to Buy at Vetr Inc
Jefferies Group LLC cut shares of Teva Pharmaceutical Industries from a "buy" rating to a "hold" rating and cut their target price for the company from $69.00 to $40.00 in a research note on Sunday, December 4th. BTIG Research downgraded shares of Teva Pharmaceutical Industries from a "buy" rating to a "neutral" rating in a report on Sunday, December 4th.

from Biotech News

Finanzen: Krankheitskosten in der Steuererklärung angeben : Außergewöhnliche Belastungen

Die Kosten für Zahnersatz oder eine Brille müssen Sie weitgehend aus eigener Tasche zahlen. Diese Ausgaben können Sie jedoch in Ihrer Steuererklärung ansetzen.

from Finanztip Feed
Supported by Video Collection

Barron's: 3 Cheap Biotechs With Powerhouse Potential

Barron's: 3 Cheap Biotechs With Powerhouse Potential
Biotech shares have fallen upon hard times amid a rising furor over high drug prices and slowing sales of older blockbusters. "After a rip-roaring six-year bull run, the Nasdaq Biotechnology Index has tumbled more than 27% since its July 2015 peak A string of lackluster drug launches has also hurt confidence in an industry built on the promise of innovation and breakthrough discoveries," Barron's reported.

from Biotech News

Durchbruch: FDA erteilt Zulassung für Avelumab

Durchbruch: FDA erteilt Zulassung für Avelumab
Merck und Pfizer haben bekannt gegeben, dass die US-amerikanische Zulassungsbehörde FDA (Food and Drug Administration) die Marktzulassung für BAVENCIO® (Avelumab) Injektion 20 mg/ml zur intravenösen Verabreichung für die Behandlung von Erwachsenen und Kindern ab 12 Jahren mit metastasiertem Merkelze...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Mundipharma plant massiven Stellenabbau

Mundipharma plant massiven Stellenabbau
Die Geschäftsleitungen von Mundipharma in Deutschland haben die Belegschaft über Pläne zur strategischen Neuausrichtung des Unternehmens informiert. Zuvor hatte das Unternehmen mit Sitz in Limburg/Lahn Wirtschaftsausschuss und Betriebsrat über die Planungen in Kenntnis gesetzt. In deren Folge würde ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

MorphoSys' Forschungsvorstand nimmt vorübergehend Auszeit

MorphoSys' Forschungsvorstand nimmt vorübergehend Auszeit
Die MorphoSys AG gab bekannt, dass ihr Vorstandsmitglied Dr. Marlies Sproll aus familiären Gründen eine vorübergehende Auszeit nehmen wird. Dr. Sproll, die seit langen Jahren im Vorstand den Bereich Forschung verantwortet, wird ihr Amt ab dem 15. April 2017 zunächst für sechs Monate ruhen lassen. Si...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

FDA approves Pfizer, German Merck immunotherapy for skin cancer

FDA approves Pfizer, German Merck immunotherapy for skin cancer
U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body. The Food and Drug Administration said it approved Bavencio, known chemically as avelumab, to treat metastatic Merkel cell carcinoma in patients 12 years and older.

from Biotech News

BIOTECanada: Federal Budget Strengthens Biotechnology Industry Ecosystem Building Canadian Economy

BIOTECanada: Federal Budget Strengthens Biotechnology Industry Ecosystem Building Canadian Economy
Importantly the budget proposes support for the acceleration of innovation through the establishment of sector specific superclusters, including health/bio-sciences, agri-food and clean technology. "The core of our industry is innovation - much of it coming out of universities.

from Biotech News

UK Stocks-Factors to watch on March 23

UK Stocks-Factors to watch on March 23
March 23 Britain's FTSE 100 index is seen opening up 12 points at 7,337 on Thursday, according to financial bookmakers. * GLAXOSMITHKLINE: Britain's GlaxoSmithKline and U.S.-based Regeneron Pharmaceuticals are embarking on a joint project with UK Biobank, the world's most detailed biomedical database, to hunt for new clues linking genes and disease.

from Biotech News

Some of the youngest opioid victims are curious toddlers

Some of the youngest opioid victims are curious toddlers
Some of the youngest victims of the nation's opioid epidemic are children under age 5 who die after swallowing adult pills. The number of children's deaths is still small relative to the overall toll from opioids, but toddler fatalities have climbed steadily over the last 10 years.

from Biotech News

Finanzen: PKV-Beitrag senken : PKV-Beitrag senken

Wenn der Beitrag der privaten Krankenversicherung zu teuer ist, gibt es verschiedene Möglichkeiten, diesen zu senken.

from Finanztip Feed
Supported by Video Collection

Drug Firm Seeks to Dismiss McDowell County Pain Pill Suit

Drug Firm Seeks to Dismiss McDowell County Pain Pill Suit
A major prescription drug distributor is asking a judge to dismiss a lawsuit alleging the company fueled West Virginia's opioid epidemic with excessively large shipment of painkillers. The Charleston Gazette-Mail reports an attorney for AmerisourceBergen said McDowell County commissioners are misguided in in blaming drug distributors for the drug problem.

from Biotech News

Finanzen: Ratgeber Baufinanzierung : Baufinanzierung

Wer optimal finanzieren möchte, braucht günstige Zinsen und ein vernünftiges Konzept. Wir zeigen Ihnen, wie Sie am besten vorgehen.

from Finanztip Feed
Supported by Video Collection

Novartis erleidet Rückschlag bei Herzmittel Serelaxin

Novartis erleidet Rückschlag bei Herzmittel Serelaxin
(dpa-AFX) Der Pharmakonzern Novartis hat einen Rückschlag erlitten. Der Hoffnungsträger RLX030 (Serelaxin) hat in der Phase-III-Studie RELAX-AHF-2 den primären Endpunkt, also die Ziele, nicht erreicht. Getestet wurde der Wirkstoff zur Behandlung von akutem Herzversagen, wie das Unternehmen am Mittwo...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

FDA erteilt Marktzulassung für Xadago für Parkinson-Patienten in den USA

FDA erteilt Marktzulassung für Xadago für Parkinson-Patienten in den USA
Newron Pharmaceuticals S.p.A. und seine Partner Zambon S.p.A. und US WorldMeds, LLC, gaben die Zulassung von Xadago(R) (Safinamide) durch die US-amerikanische Behörde FDA (Food and Drug Administration) zur Behandlung der Parkinson-Krankheit als Zusatztherapie zu Levodopa/Carbidopa bekannt. Von der P...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Stada sorgt für Unruhe mit Verschiebung des Jahresabschlusses

Stada sorgt für Unruhe mit Verschiebung des Jahresabschlusses
(dpa-AFX) Mit der überraschenden Verschiebung der Bilanzvorlage hat der von Finanzinvestoren umworbene Arzneimittelhersteller Stada die Anleger verunsichert. Die Stada-Aktie fiel bis zum Schluss des Xetra-Handels am Dienstag um mehr als 3 Prozent und erholte sich auch im nachbörslichen Handel auf de...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Spatenstich bei GSK für Meningokokken-B-Impfstoff-Produktion in Marburg

Изображение
Spatenstich bei GSK für Meningokokken-B-Impfstoff-Produktion in Marburg

Am 20. März wurden die Bauarbeiten für den Neubau der Meningokokken-B-Anlage mit einem symbolischen Spatenstich durch das GSK-Management sowie durch hessische und lokale Politiker eingeleitet. Mit einem Investitionsvolumen von 162 Mio. EUR setzt der Konzern auch nach dem Bau eines neuen Mitarbeiterr...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Lisa Holst Joins NorthStar Medical Radioisotopes as Vice President of Sales and Marketing

Lisa Holst Joins NorthStar Medical Radioisotopes as Vice President of Sales and Marketing
Holst has more than 25 years of sales and marketing experience in the pharmaceutical and medical imaging industries, most recently as senior director of marketing at Navidea Biopharmaceuticals. She joins NorthStar as it advances toward U.S. Food and Drug Administration approval of its RadioGenixa intelligent isotope separation system and its non-fission, non-uranium-based brand of the medical radioisotope molybdenum-99 .

from Biotech News

PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing

PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing
PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , today announced that it has filed a provisional patent application with the United States Patent and Trademark Office to protect its therapy to treat cancerous tumors, including the therapy that will be used in its upcoming clinical trial in locally advanced pancreas cancer .

from Biotech News

U.S. bans Indian drugmaker Divi's factory, shares hit 3-year low

U.S. bans Indian drugmaker Divi's factory, shares hit 3-year low
U.S. health regulators have banned a drug production site in India belonging to Divi's Laboratories Ltd due to manufacturing violations, sending the company's shares down to a near three-year low on Wednesday. This comes at a time when an increasingly protectionist stance by U.S. President Donald Trump is threatening to make the operating environment tougher for India's drugmakers that supply nearly a third of the medicines sold in the United States - the world's largest healthcare market.

from Biotech News

BPCIA Helps Amgen Gain Dismissal of Genentech Complaint

BPCIA Helps Amgen Gain Dismissal of Genentech Complaint
Recently, the U.S. District Court of Delaware dismissed a complaint filed by Genentech under the Biologics Price Competition and Innovation Act . The complaint was filed in response to Amgen seeking FDA approval to commercialize a biosimilar version of Genentech's cancer drug, Avastin.

from Biotech News

Fortress Biotech Inc (FBIO) Cut to Sell at Zacks Investment Research

Fortress Biotech Inc (FBIO) Cut to Sell at Zacks Investment Research
According to Zacks, "Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products.

from Biotech News

Billionaires' Best Healthcare Stock Picks of 2017

Billionaires' Best Healthcare Stock Picks of 2017
Billionaire investors didn't amass their fortunes by picking horrible stocks. While you wouldn't want to blindly copy these successful investors, it certainly doesn't hurt to watch which stocks they choose and how those stocks perform.

from Biotech News

With Ackman Out, Valeant Confronts Rocky Road to Revival

With Ackman Out, Valeant Confronts Rocky Road to Revival
Even before Valeant Pharmaceuticals International Inc. lost its most vocal cheerleader last week, with the exit of hedge-fund mogul Bill Ackman, Wall Street analysts were virtually unanimous: the company's old business model is broken. Growth, if there is any, will come slowly.

from Biotech News

ACTEGA North America Hires New Marketing Communications Manager

ACTEGA North America Hires New Marketing Communications Manager
ACTEGA NA , the North American division of global specialty ink, coatings, and sealants company Altana AG, is pleased to announce the addition of Kristin Tripoli to their NJ-based marketing team. Kristin will be managing ACTEGA's North American trade show presence as well as developing advertising programs, product launches, website and digital platforms, and collateral materials for the company's 5 market segments .

from Biotech News

Biogen Inc (BIIB) to Post Q1 2017 Earnings of $4.65 Per Share, Leerink Swann Forecasts

Biogen Inc (BIIB) to Post Q1 2017 Earnings of $4.65 Per Share, Leerink Swann Forecasts
Leerink Swann dropped their Q1 2017 earnings per share estimates for shares of Biogen in a note issued to investors on Thursday. Leerink Swann analyst G. Porges now expects that the firm will post earnings per share of $4.65 for the quarter, down from their prior forecast of $4.70.

from Biotech News

Array Biopharma Inc (ARRY) Raised to Hold at Vetr Inc.

Array Biopharma Inc (ARRY) Raised to Hold at Vetr Inc.
The firm currently has a $9.99 target price on the biopharmaceutical company's stock. Vetr 's price target indicates a potential downside of 0.79% from the stock's current price.

from Biotech News

Positive Clinical Results for Using Myriad's BRACAnalysis...

Positive Clinical Results for Using Myriad's BRACAnalysis...
Myriad Genetics recently announced clinical results showing that its BRACAnalysis CDx test was able to identify patients with HER2-negative metastatic breast cancer who had improved response with Lynparza , AstraZeneca's PARP inhibitor. The results are based on a collaborative effort between Myriad Genetics and AstraZeneca for identification and treatment of patients with metastatic breast cancer and underlying BRCA 1/2 mutations.

from Biotech News

A small drug company that's trying to make cancer treatments safer...

A small drug company that's trying to make cancer treatments safer...
CytomX, a biotech that's developing safer ways to administer cancer immunotherapies, just got another $200 million from drug giant Bristol-Myers Squibb. Bristol-Myers has two drugs, Opdivo and Yervoy, that are a part of a new class of cancer treatments called cancer immunotherapy that harness the body's immune system to go after cancer.

from Biotech News

Finanzen: Günstige Bahn-Tickets : Deutsche Bahn

Bahn fahren ist komfortabel, manchen aber zu teuer. So kommen Sie an günstigere Fahrkarten.

from Finanztip Feed
Supported by Video Collection

Peak time for flu, colds: Why does sickness surge in winter's chilly temperatures?

Peak time for flu, colds: Why does sickness surge in winter's chilly temperatures?
METRO CREATIVE CONNECTIONAs winter drags on, so does the season for colds, stomach viruses, strep and the flu. Many illnesses occur most frequently in the winter months - And peak season can last through May. Winter is prime season for influenza, according to the Centers for Disease Control and Prevention.

from Biotech News

Perrigo Company plc (PRGO) Given a $86.00 Price Target at Canaccord Genuity

Perrigo Company plc (PRGO) Given a $86.00 Price Target at Canaccord Genuity
The brokerage presently has a "buy" rating on the stock. Canaccord Genuity's price objective indicates a potential upside of 23.74% from the stock's current price.

from Biotech News

Finanzen: Befristeter Arbeitsvertrag : Befristeter Arbeitsvertrag

Jeder zwölfte Arbeitsvertrag ist befristet. Für Arbeitnehmer kann ein Zeitvertrag die Chance bieten, Berufserfahrung zu sammeln. Bestenfalls klappt der Wechsel zur Festanstellung. Junge Frauen sind durch befristete Verträge allerdings benachteiligt.

from Finanztip Feed
Supported by Video Collection

Neogen Co. (NEOG) Cut to "Hold" at Zacks Investment Research

Neogen Co. (NEOG) Cut to "Hold" at Zacks Investment Research
According to Zacks, "Neogen Corporation develops, manufactures, and markets a diverse line of products dedicated to food and animal safety. The company's food safety segment consists primarily of diagnostic test kits and related products, including dehydrated culture media, marketed to food producers and processors to aid in the detection of foodborne bacteria, natural toxins, food allergens, drug residues, pesticide residues, plant disease infections and levels of general sanitation.

from Biotech News

Finanzen: Schadenfreiheitsrabatt übertragen : Schadenfreiheitsrabatt übertragen

Sie können Ihre Schadenfreiheitsklasse auf einen nahen Verwandten übertragen, so dass dieser sich viel Geld spart. Wie das geht, erfahren Sie hier.

from Finanztip Feed
Supported by Video Collection

Finanzen: Strompreis : Strompreise

Seit dem Jahr 2000 haben sich die Strompreise für private Haushalte verdoppelt. Seit 2013 blieb der Preis der Elektrizität im Durchschnitt konstant. Die Preisunterschiede zwischen den einzelnen Abietern sind jedoch enorm.

from Finanztip Feed
Supported by Video Collection

Shire PLC (SHP) Rating Reiterated by Royal Bank of Canada

Shire PLC (SHP) Rating Reiterated by Royal Bank of Canada
's stock had its "outperform" rating reissued by equities researchers at Royal Bank of Canada in a report released on Monday. Other research analysts have also recently issued research reports about the stock.

from Biotech News

MITIE Group PLC (MITFY) Rating Increased to Hold at Zacks Investment Research

MITIE Group PLC (MITFY) Rating Increased to Hold at Zacks Investment Research
According to Zacks, "Mitie Group plc provides strategic outsourcing services. The company's operating segment includes Soft FM, Hard FM, Property Management and Healthcare.

from Biotech News

Renaissance Technologies LLC Has $86,967,000 Position in Celgene Co.

Renaissance Technologies LLC Has $86,967,000 Position in Celgene Co.
Renaissance Technologies LLC lowered its stake in shares of Celgene Co. by 38.7% during the fourth quarter, Holdings Channel reports.

from Biotech News

Infinity Pharmaceuticals Inc. Forecasted to Post Q1 2017 Earnings of

Infinity Pharmaceuticals Inc. Forecasted to Post Q1 2017 Earnings of
Infinity Pharmaceuticals Inc. - Stock analysts at William Blair issued their Q1 2017 EPS estimates for Infinity Pharmaceuticals in a note issued to investors on Wednesday. William Blair analyst Y. Xu forecasts that the brokerage will earn per share for the quarter.

from Biotech News

Endo International plc - (ENDP) Given a $14.00 Price Target at Canaccord Genuity

Endo International plc - (ENDP) Given a $14.00 Price Target at Canaccord Genuity
The firm currently has a "hold" rating on the stock. Canaccord Genuity's target price suggests a potential upside of 30.11% from the stock's current price.

from Biotech News

Schutter Richard Urbain De Buys 10,000 Shares of Valeant Pharmaceuticals Intl Inc (VRX) Stock

Schutter Richard Urbain De Buys 10,000 Shares of Valeant Pharmaceuticals Intl Inc (VRX) Stock
Valeant Pharmaceuticals Intl Inc Director Schutter Richard Urbain De acquired 10,000 shares of the business's stock in a transaction that occurred on Wednesday, March 15th. The shares were purchased at an average cost of C$10.80 per share, for a total transaction of C$108,000.00.

from Biotech News

SPDR S&P Biotech (Xbi) Announces Dividend Increase - $0.02 Per Share

SPDR S&P Biotech (Xbi) Announces Dividend Increase - $0.02 Per Share
SPDR S&P Biotech announced a quarterly dividend on Friday, March 17th. Shareholders of record on Tuesday, March 21st will be paid a dividend of 0.0197 per share on Monday, March 27th.

from Biotech News

3 Companies That Need to Kick Their CEO to the Curb

3 Companies That Need to Kick Their CEO to the Curb
All three companies are struggling to overcome obstacles that may be holding down their stock price, and it may take A highly contentious showdown for the control of Immunomedics suggests that it may be time for founder and board member David Goldenberg and his wife, CEO Cynthia Sullivan, to head for the exit. Immunomedics inked a deal to license commercial rights to its lead product candidate, IMMU-132, last month, but the deal drew the ire of venBio, an activist hedge fund that's been advocating for significant change in the C-suite, and that owns about 10% of the company.

from Biotech News

#CuriousGoat: How To Prepare For A Pandemic

#CuriousGoat: How To Prepare For A Pandemic
They had the right idea: During the worldwide flu epidemic that began in 1918, women in this U.S. office wore cloth masks. No matter how you slice it, outbreaks are becoming more common.

from Biotech News

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings
They will be hosting a discovery day event on March 30 in Waltham to co... )--Re: First Gulf Bank P.J.S.C. USD 10,000,000.00 MATURING: 21-Jun-2021 ISIN: XS1435233066 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Mar-2017 TO 21-Jun-2017... )--Re: ALBION NO.

from Biotech News

3 Best Pharmaceutical Stocks for Long-Term Investors

3 Best Pharmaceutical Stocks for Long-Term Investors
People needed prescription drugs 20 years ago. They need them now. They'll need them 20 years from now, too.

from Biotech News